Lifestyle and sleep
Weight loss has the clearest dose-response relationship with testosterone. Longitudinal data from the European Male Ageing Study showed that losing under 15% of body weight raised total testosterone by about 58 ng/dL, while losing more than 15% raised it by roughly 164 ng/dL and moved free testosterone too. In obese men with type 2 diabetes, Vito Giagulli's Italian team found that 94% of patients achieving more than 10% weight loss saw testosterone rise, while glycemic control alone did nothing.
Resistance training and seven or more hours of sleep belong in the andropause treatment plan. Be clear-eyed about what they do, though. A meta-analysis in Frontiers in Physiology found that resistance training did not significantly change basal testosterone in older men. It reliably built strength. Lifting improves the outcome you care about without necessarily moving the number, and none of these measures corrects genuine hypogonadism from testicular or pituitary disease.
Contributing condition care
When the evaluation turns up a treatable cause, treating it is andropause treatment. CPAP for sleep apnea improves erectile function on its own, with meta-analytic data showing resolution of erectile dysfunction in 75% of patients in one series, alongside quality-of-life gains. Reviewing an opioid regimen with the prescribing clinician and treating depression both address symptoms directly.
This work runs in parallel with hormone therapy when both are warranted, and it replaces hormone therapy when the deficiency turns out to be functional. Low testosterone after 40 driven by obesity or untreated apnea improves once the driver is handled.
Testosterone replacement therapy
Testosterone replacement therapy (TRT) helps men who have symptoms and repeatedly low levels after a real evaluation. In those men, it improves libido and erectile function compared with placebo. It also corrects unexplained anemia and raises bone density at the spine and hip.
What andropause treatment isn't is an anti-aging protocol or a reasonable response to one abnormal result. Testosterone prescribing in the US rose from 0.52% of men in 2002 to a peak before falling after the 2015 FDA labeling change, and that surge tracked direct-to-consumer marketing. Bhasin's task force noted in its 2018 guideline announcement that many men are prescribed testosterone without an appropriate diagnostic workup or monitoring plan.
When TRT needs caution
Some conditions rule TRT out. Active prostate or breast cancer are absolute contraindications, since both are androgen-responsive. So are uncontrolled erythrocytosis and an unevaluated prostate-specific antigen (PSA) above 4 ng/mL.
The AUA guideline sets specific numbers on the blood side. Every patient gets a baseline hemoglobin and hematocrit, and if hematocrit exceeds 50%, clinicians withhold therapy until the cause is investigated. Injectable formulations produce the largest increases, so the choice of delivery method carries risk implications.
Severe lower urinary tract symptoms and inadequately controlled heart failure both call for delay and reassessment. The cardiovascular question has been partly answered: the TRAVERSE trial randomized 5,246 men aged 45 to 80 with existing or high-risk cardiovascular disease and found testosterone noninferior to placebo for cardiac death and nonfatal heart attack. Investigators still recorded more atrial fibrillation and pulmonary embolism in the testosterone arm than expected, and a separate substudy found a higher fracture risk with a hazard ratio of 1.43. Individualized risk assessment isn't a formality.
Fertility and monitoring
External testosterone shuts down the signalling that drives sperm production. World Health Organization contraceptive trials recorded azoospermia in 64% to 75% of men within six months on testosterone enanthate, and the same review notes that suppression occurs in 65% of normospermic men within four months. If fatherhood is on the table, that conversation happens before the first dose, and options include sperm banking, human chorionic gonadotropin co-therapy, or clomiphene instead of testosterone.
Recovery is usual but slow. Pooled data show sperm density returning above 20 million/mL in 84% of men after a median of 3.7 months, though only 46% get back to their own baseline density, and a small minority never fully recover.
Monitoring on andropause treatment is straightforward and non-negotiable. Testosterone level and hematocrit at 3 to 6 months, again at 12 months, then annually. A hematocrit at or above 54% warrants dose reduction, temporary discontinuation, or therapeutic phlebotomy. PSA gets measured in men over 40 before starting, and the Endocrine Society recommends urologic referral if serum PSA rises more than 1.4 ng/mL above baseline or crosses 4 ng/mL. If symptoms haven't improved after a reasonable trial, stopping is the right call.
Start with an assessment
Persistent fatigue, changed libido, or erectile difficulty that has lasted months deserves a workup rather than a guess. The evaluation costs you a morning, and it either finds a treatable cause or confirms low testosterone after 40 as a hormone deficiency worth treating.
TNT Wellness provides lab-based hormone assessment for men in the Charlotte area, with total and free testosterone panels and individualized treatment planning under medical direction. Book a men's hormone assessment to get diagnostic testing and a straight discussion about whether andropause treatment fits your situation.